2-Year ATTRACT Data: Anticoagulation Alone Best for Most DVT; PCDT Benefits Seen in Certain Iliofemoral Patients
March 6, 2017—The much-anticipated 2-year results from the ATTRACT study were presented by Suresh Vedantham, MD, FSIR, on behalf of the trial’s investigators, at the 2017 Society of Interventional Radiology (SIR) Annual Scientific Meeting.